There Are Alternati...
Health Care: Drugs
Targacept Inc. (TRGT: NASDAQ)
$6.28 -0.04 | -0.63%
02/08/12 - 04:00 PM ET
328.79K / 1.11M
Vol / Avg. Vol:6.35 / 6.32
Open / Prev. Close:6.19 - 6.46
Today's Range:4.91 - 30.47
52 Wk Range:12.75%
Performance YTD:TheStreet Rating:
Portfolios with TRGT
- Portfolio NameUser Type
- UserMiriam Hoath
- ContributorStocks Under-$10 Setting Up...
- Contributor10 Biotech Stocks Loved and...
- ContributorHot Biotech Trades for Seco...
- UserMoney
- UserBVF Inc.
- UserRAPTOR SPRTD EXTREME FUTURE...
- UserRamsFavs
- UserSUPRATRADE-STEALTH PROJECT
- UserBookIT837643
Latest TRGT Headlines from TheStreet
- Targacept Stock Gaps Down On Today's Open (TRGT) 12.20.11 | 09:12 am
- 5 Stocks Under $10 Set to Soar 12.16.11 | 01:12 pm
- Targacept Bulls Seek Major Rebound 12.13.11 | 05:12 am
- Targacept Inc. Stock Downgraded (TRGT) 12.07.11 | 05:12 am
- Targacept Stock Hits New 52-Week Low (TRGT) 11.21.11 | 10:11 am
- Targacept Rises On Unusually High Volume (TRGT) 11.09.11 | 09:11 am
- Targacept Trial Tragedy Takeaway: Don't Trust Clinical Data From India 11.08.11 | 12:11 pm
- Targacept Stock Hits New 52-Week Low (TRGT) 11.08.11 | 09:11 am
- Market Morning: Italy Fears Roil Markets 11.08.11 | 07:11 am
- Targacept Depression Drug Fails Late-Stage Study 11.08.11 | 06:11 am
Press Releases for TRGT
- Targacept To Report Fourth Quarter And 2011 Financial Results On February 21, 2012 - Business Wire 02.07.12 | 08:02 am
- Targacept Announces Participation In Upcoming Conferences - Business Wire 02.06.12 | 08:02 am
- Targacept Announces Decision By AstraZeneca To Advance AZD1446 In Alzheimer’s Disease - Business Wire 01.05.12 | 08:01 am
- Targacept To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire 01.04.12 | 08:01 am
- AstraZeneca And Targacept Announce Top-line Results From Second Phase 3 Study Of TC-5214 As An Adjunct Treatment In Patients With Major Depressive Disorder - Business Wire 12.20.11 | 02:12 am
- Targacept Announces Initiation Of Two Phase 2 Studies Of TC-5619 - Business Wire 12.05.11 | 08:12 am
- Targacept Announces Participation In Upcoming Conferences - Business Wire 11.28.11 | 08:11 am
- Targacept To Present At The Lazard Capital Markets 8th Annual Healthcare Conference - Business Wire 11.11.11 | 04:11 pm
- Targacept To Host Conference Call Today At 10:00 AM To Discuss Top-line Results From RENAISSANCE 3 Study Of TC-5214 As An Adjunct To Antidepressant Treatment For Major Depressive Disorder - Business Wire 11.08.11 | 02:11 am
- AstraZeneca And Targacept Announce First Top-line Phase 3 Results For TC-5214 As An Adjunct Treatment In Patients With Major Depressive Disorder - Business Wire 11.08.11 | 02:11 am
Partner Headlines for TRGT
- Morning Market Losers - Benzinga 12.20.11 | 09:12 am
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
- Learning A Tough Lesson With Targacept - Seeking Alpha 11.10.11 | 09:11 am
- Targacept's Depressing Plunge As Antidepressant Fails - Seeking Alpha 11.09.11 | 08:11 am
- Friday Options Recap - Seeking Alpha 10.14.11 | 04:10 pm
- Are These 10 Sick Healthcare Companies Terminally Ill? - Seeking Alpha 07.07.11 | 09:07 am
- Top 15 Most Undervalued Biotech Stocks By Analyst Target Price - Seeking Alpha 04.08.11 | 03:04 pm
- Pipeline Setback for Targacept - Analyst Blog - Zacks 03.28.11 | 09:03 pm
- Life Science Portfolios: Reflecting on a Year of Out-Performance - Seeking Alpha 12.29.10 | 05:12 am
- Deutsche Bank Initiates Coverage on Targacept - Benzinga 11.19.10 | 09:11 am
